Rein Therapeutics is headquartered in Austin, Texas.
Rein Therapeutics disclosed revenue of 15M USD for 2023 and 28M USD for 2022.
Rein Therapeutics has 11 employees.
Rein Therapeutics is a life science company.
Rein Therapeutics was founded in 2001.
12407 N. Mopac Expy. Suite 250 #390,
Austin, Texas
78758
United States,
(737) 802-1989
www.reintx.com
Rein Therapeutics is focused on advancing a pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications. The company's lead product candidate, LTI-03, is in a Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis. LTI-03 is a novel, synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. Its second product candidate, LTI-01, is a proenzyme that has completed Phase 1b and Phase 2a clinical trials for the treatment of loculated pleural effusions. LTI-01 has received Orphan Drug Designation in the US and EU and Fast Track Designation in the US. Rein Therapeutics was founded in 2001 and is based in Austin, Texas.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | 1 | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
| Financial | Deals |
|---|---|
|
Ladenburg Thalmann & Co. |
1 |
| Legal | Deals |
|---|---|
|
Wilmer Cutler Pickering Hale and Dorr |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
